Study of an experimental drug for adults with high triglycerides
This early-phase trial tests an experimental drug called FXR0906 in healthy adults who have elevated triglycerides (a type of fat in the blood). It aims to see if the drug is safe and how it affects cholesterol and fat levels, which may help prevent heart disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 55 years old.
- Your body mass index (BMI) must be between 18 and 35.
- Your fasting triglycerides (a blood fat) must be above 80 mg/dL (0.90 mmol/L).
- Your fasting LDL (bad cholesterol) must be at least 70 mg/dL (1.81 mmol/L).
- You must not have diabetes or prediabetes (fasting blood sugar below 7.0 mmol/L and HbA1c below 6.5%).
- You must not have used any cholesterol-lowering medications or supplements in the past 30 days, or certain gene-targeting therapies in the past year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental drug called DR10624 compared to a placebo in people with severely high triglycerides (fats in the blood). It aims to see if the drug can safely lower these fats and reduce the risk of related health problems like pancreatitis.
This trial tests a new injectable drug, JMT202, for people with high triglycerides (a type of fat in the blood). The goal is to see if it safely lowers triglycerides and may reduce heart risk.
This trial tests an investigational medication, MAR001, to see if it can lower high levels of fats in the blood (triglycerides and remnant cholesterol) linked to heart disease. If you have these conditions, this treatment might help reduce your risk.
This trial tests a new medication, SHR-1918, to lower high triglyceride levels. It may be an option for people with moderately elevated triglycerides and controlled cholesterol.
This trial tests a new medicine, CTX310, for people with persistently high levels of fats (triglycerides) and cholesterol that have not improved with standard treatments. It aims to see if the drug is safe and tolerable.
This trial tests a new medicine called ISH0688 for safety and how the body processes it. It has two parts: one in healthy volunteers and one in people with high triglycerides, to see if the drug can help lower fats in the blood.
Hear when a new Healthy Adult Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.